Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Haotian Yang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Branch of Animal Husbandry and Veterinary of Heilongjiang Academy of Agricultural Sciences, Qiqihar 161005, China. Hauptthemen laut MEDLINE: NADPH Oxidase 4, NF-E2-Related Factor 2, Dexmedetomidine, Oxidative Stress. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: China Agriculture Research System, Heilongjiang Academy of Agricultural Sciences Branch of Animal Husbandry and Veterinary Branch.
Abstract (Originalsprache)
Objectives
The study aimed to investigate the protective effects of dexmedetomidine (DEX) on renal injury caused by acute stress in rats and explore the protective pathways of DEX on rat kidneys in terms of oxidative stress.
Methods
An acute restraint stress model was utilized, where rats were restrained for 3 hours after a 15-minute swim. Biochemical tests and histopathological sections were conducted to evaluate renal function, along with the measurement of oxidative stress and related pathway proteins. Key findings The open-field experiments validated the successful establishment of the acute stress model. Acute stress-induced renal injury led to increased NADPH oxidase 4 (NOX4) protein expression and decreased expression levels of nuclear transcription factor 2 (Nrf2), heme oxygenase-1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1). Following DEX treatment, there was a significant reduction in renal NOX4 expression. The DEX-treated group exhibited normalized renal biochemical results and less damage observed in pathological sections compared to the acute stress group.
Conclusions
The findings suggest that DEX treatment during acute stress can impact the NOX4/Nrf2/HO-1/NQO1 signaling pathway and inhibit oxidative stress, thereby preventing acute stress-induced kidney injury. Additionally, DEX shows promise for clinical applications in stress syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Branch of Animal Husbandry and Veterinary of Heilongjiang Academy of Agricultural Sciences, Qiqihar 161005, China.
- Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.
- College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, 266109, China.
- Soybean Research Institute, Heilongjiang Academy Agriculturalof Science, Haerbin,150086, China.
ORCID-Profile: Zhifeng Chen
Förderung
- China Agriculture Research System
- Heilongjiang Academy of Agricultural Sciences Branch of Animal Husbandry and Veterinary Branch
Zitieren
APA
Yang, H., Chen, Y., Wang, Z., Huang, Y., Ma, Z., Zou, Y., Dong, J., Zhang, H., Huo, M., Lv, M., Liu, X., Zhang, G., Wang, S., Yang, K., Zhong, P., Jiang, B., Kou, Y., & Chen, Z. (2024). Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae044
Vancouver
Yang H, Chen Y, Wang Z, Huang Y, Ma Z, Zou Y, et al. Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae044
BibTeX
@article{Yang2024,
author = {Yang, Haotian and Chen, Yongping and Wang, Zhiqiang and Huang, Yuxiang and Ma, Zhigang and Zou, Yue and Dong, Jiaqiang and Zhang, Hong and Huo, Mingdong and Lv, Mingzhe and Liu, Xuesong and Zhang, Guohua and Wang, Shuang and Yang, Kun and Zhong, Peng and Jiang, Botao and Kou, Yuhong and Chen, Zhifeng},
title = {Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae044}
}
EUVIMED